News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Roberto Ferrara: Neoadjuvant versus perioperative chemo-immunotherapy according to pathological response in resectable NSCLC
Roberto Ferrara/X
Apr 15, 2025, 07:09

Roberto Ferrara: Neoadjuvant versus perioperative chemo-immunotherapy according to pathological response in resectable NSCLC

Roberto Ferrara, Medical Oncologist,Researcher in Thoracic Oncology and Molecular Immunology at Vita-Salute San Raffaele University, posted on X about recent paper he and his colleagues co-authored:

“Time to tailor chemo-IO in resected NSCLC.

Reconstructed individual pts data show NEOAD= PERIOP in pCR, MPR, non-MPR. PERIOP performs well in pure-MPR (1-10%RVT). pCR or no-MPR deserve descalation or escalation strategies.”

Neoadjuvant versus perioperative chemo-immunotherapy according to pathological response in resectable NSCLC: a reconstructed individual patient data meta-analysis.

Authors: Antonio Nuccio, Roberto Ferrara, et al.

Roberto Ferrara

More posts featuring NSCLC.

cancer immunotherapy Lung cancer NSCLC OncoDaily Oncology Roberto Ferrara
Special Coverage
Blog
Apr 15, 2025, 07:40
Estela Rodriguez: The second-line options for EGFR lung cancer beyond platinum-chemo after best therapies upfront
Blog
Apr 15, 2025, 07:23
EACR about their affiliated journal, Molecular Oncology
Blog
Apr 15, 2025, 07:21
Enrolling for the ComboMATCH Treatment Trial E5 - ECOG-ACRIN Cancer Research Group
Opinion
Apr 15, 2025, 07:10
The NCCN 2025 Breast Cancer Congress recorded presentations are now available
Blog
Apr 15, 2025, 07:09
Roberto Ferrara: Neoadjuvant versus perioperative chemo-immunotherapy according to pathological response in resectable NSCLC
Blog
Apr 15, 2025, 07:04
Imane Bensalim: Honored to have participated in Sim Africa 2025
Blog
Apr 15, 2025, 06:40
The application for the 2025 Ambassador Program is open - American Society of Hematology
Blog
Apr 15, 2025, 06:16
Applications for the ENYGO Introduction to Robotic Surgery Course close May 12 - ESGO
Blog
Apr 15, 2025, 05:15
Don't miss the NCI Rising Scholars Cancer Research Seminar Series featuring Dr. Juan C. Osorio - Train at NCI
Blog
Apr 15, 2025, 04:10
Sally Wolf: 7 years with Stage IV cancer
Blog
Apr 15, 2025, 02:28
Beth Dickson-Gavney: It is an honor to connect with fellow colleagues at Texas Lung 25 this week
Blog
Apr 14, 2025, 19:10
Douglas Flora: How 50,000 screenings are transforming lung cancer care